Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
L Antigen Family Member 1a (LAGE-1a) is a tumor-associated antigen belonging to the ESO/LAGE family of cancer-testis antigens. It is encoded by the CTAG2 gene and exhibits restricted expression primarily in cancerous tissues and testicular germ cells, making it a target for cancer immunotherapy. LAGE-1a can elicit immune responses and is being explored for targeted therapies such as therapeutic vaccines or adoptive T-cell therapies.
Therapeutic vaccines or adoptive T-cell therapies aimed at treating cancers expressing this antigen
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on L Antigen Family Member 1a (None).